BRIEF published on 11/14/2025 at 15:35, 3 months 20 days ago Grünenthal Expands Bond Offering by €175 Million Financial Results Pharmaceutical Debt Issuance Grünenthal Bond Extension
PRESS RELEASE published on 11/14/2025 at 15:30, 3 months 20 days ago Grünenthal announces pricing of bond extension Grünenthal extends Senior Secured Notes by €175 million to a total of €675 million with 4.625% interest rate and maturity in 2031 Pharmaceutical Company Senior Secured Notes Grünenthal Debt Issue Bond Extension
BRIEF published on 03/27/2025 at 09:36, 11 months 9 days ago Grünenthal Reports Strong 2024 Financial Results Financial Results Strategic Growth US Market Expansion Grünenthal 2024 Valinor Acquisition
PRESS RELEASE published on 03/27/2025 at 09:31, 11 months 9 days ago Grünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US Grünenthal reports exceptional 2024 financial results driven by strategic growth and Valinor acquisition in the US Financial Results 2024 Strategic Growth Grünenthal Valinor Acquisition
BRIEF published on 12/06/2024 at 13:22, 1 year 2 months ago Grünenthal Successfully Issues €500 Million Bond Bond Issuance Grünenthal Maturity Profile €500 Million Finance Strategy
PRESS RELEASE published on 12/06/2024 at 13:17, 1 year 2 months ago Grünenthal successfully places new €500 million bond Grünenthal GmbH successfully places new €500 million bond to strengthen capital structure and pursue growth strategy, enhancing flexibility for investments and innovation Growth Strategy Bond Capital Structure Debt Issue Grünenthal GmbH
BRIEF published on 11/27/2024 at 09:40, 1 year 3 months ago Grünenthal Announces €500 Million Bond Pricing Bond Issuance Credit Ratings Debt Refinancing €500 Million Grünenthal GmbH
PRESS RELEASE published on 11/27/2024 at 09:35, 1 year 3 months ago Grünenthal announces pricing of €500 million bond Grünenthal GmbH announces pricing of €500 million bond to enhance capital structure and maturity profile. New financing to refinance existing debt and repurchase outstanding notes Bond Finance Debt Pricing Grünenthal GmbH
BRIEF published on 03/25/2024 at 09:35, 1 year 11 months ago Grünenthal Announces Strong Financial Results for 2023 with Continued Focus on R&D and Strategic Acquisitions Pharmaceuticals Annual Results Strategic Acquisitions Grünenthal R&D Investment
PRESS RELEASE published on 03/25/2024 at 09:30, 1 year 11 months ago Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions Acquisitions 2023 Results Record Revenue R&D Investments Grünenthal
Published on 03/05/2026 at 13:40, 15 minutes ago Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
Published on 03/05/2026 at 13:30, 25 minutes ago Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend
Published on 03/05/2026 at 13:30, 25 minutes ago Nextech3D.ai Expands AI Event Technology Into New Markets and Implements 20%-30% Enterprise Price Increase
Published on 03/05/2026 at 13:00, 55 minutes ago Revolve Signs Definitive Agreements for Portfolio of 16 Distributed Generation Solar Projects in Mexico
Published on 03/05/2026 at 13:00, 55 minutes ago Field Work Identifies New Mineralized Trend and Additional Gold Targets at Golden Rose
Published on 03/05/2026 at 13:43, 12 minutes ago Healthcare specialist SHS Capital exits AMW, a leading specialty pharma company, and continues partnership by reinvesting with its current fund as part of a syndicate of investors
Published on 03/05/2026 at 13:25, 30 minutes ago Huawei and SOLUM Unveil Shop-in-Shop Smart Converged Network Solution to Accelerate Retail Intelligence
Published on 03/05/2026 at 13:06, 48 minutes ago HENSOLDT acquires Nedinsco and expands its European presence
Published on 03/05/2026 at 13:05, 50 minutes ago Norgine announces £23 million new investment as part of more than £50 million committed to expanding medicines manufacturing in Wales
Published on 03/05/2026 at 13:00, 55 minutes ago Huawei Launches AI Data Platform to Bridge Models and Business Value
Published on 03/04/2026 at 23:50, 14 hours 5 minutes ago Total number of voting rights and shares making up the share capital at February 28, 2026
Published on 03/04/2026 at 18:00, 19 hours 55 minutes ago Disclosure of Share Capital and Voting Rights as of February 28, 2026
Published on 03/04/2026 at 17:45, 20 hours 10 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
